Clinical trial
Influence of Novel Intravascular Ultrasound-Based Artificial Intelligence Technologies on Event Reduction Following Percutaneous Coronary Intervention (INNOVATE-PCI)
NCT05807841 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Novel Intravascular Ultrasound-Based Artificial Intelligence Technologies on Event Reduction Following Percutaneous Coronary Intervention (INNOVATE-PCI)
- Lead sponsor
- Asan Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 20, 2020
- Completion date
- December 31, 2029
- Enrollment
- 3,000 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.